GlassScriptPhysician profile
Neetu Singh
NPI 1891962916
$766.55
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $289 · 2024: $295 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.55 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.88 | 2023-2025 | Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $117.00 | 2023 | Bexsero |
| Exact Sciences Corporation | $91.49 | 2023-2025 | Cologuard Collection Kit |
| Chiesi USA, INC. | $70.00 | 2023 | Curosurf |
| Novo Nordisk INC | $57.30 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Philips North America LLC | $43.28 | 2025 | Extended Holter |
| Abbott Laboratories | $37.35 | 2023-2024 | Freestyle Libre 3 |
| Pfizer INC. | $36.43 | 2024 | |
| Photonicare INC | $34.82 | 2025 | Otosight Middle Ear Scope |
| Sanofi-Aventis U.S. LLC | $32.42 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.76 | 2024 | |
| Medtronic, INC. | $20.76 | 2025 | Inceptiv |
| Merck Sharp & Dohme LLC | $19.73 | 2024 | |
| Corcept Therapeutics | $18.33 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neetu Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.